Genome scan study of prostate cancer in Arabs: Identification of three genomic regions with multiple prostate cancer susceptibility loci in Tunisians

Journal of Translational Medicine

Volumn 11, Issue 1, 2013, Pages

  Shan, Jingxuan ^a   Al Rumaihi, Khalid ^b   Rabah, Danny ^c   Al Bozom, Issam ^b   Kizhakayil, Dhanya ^a   Farhat, Karim ^c   Al Said, Sami ^b   Kfoury, Hala ^c   Dsouza, Shoba P ^a   Rowe, Jillian ^a   Khalak, Hanif G ^a   Jafri, Shahzad ^a   Aigha, Idil I ^a   Chouchane, Lotfi ^a  

^a WEILL CORNELL MEDICAL COLLEGE   (Qatar)

^b HAMAD MEDICAL CORPORATION   (Qatar)

^c KING SAUD UNIVERSITY   (Saudi Arabia)

Author keywords

Arab population; GWAS; Prostate cancer

Indexed keywords

MESSENGER RNA;

AGED; ANALYTICAL EQUIPMENT; ARAB; ARTICLE; BIOASSAY; CANCER RISK; CHROMOSOME 17; CHROMOSOME 17Q; CHROMOSOME 22Q; CHROMOSOME 9P; CHROMOSOME STRUCTURE; CONTROLLED STUDY; DISEASE ASSOCIATION; ETHNIC GROUP; GENE; GENE LOCUS; GENETIC ASSOCIATION; GENETIC SUSCEPTIBILITY; GENOME ANALYSIS; GENOTYPE; HUMAN; MAJOR CLINICAL STUDY; MALE; PROSTATE CANCER; QATAR; QUANTITATIVE TRAIT LOCUS; RNA ANALYSIS; SAUDI ARABIA; SINGLE NUCLEOTIDE POLYMORPHISM; STAT5B GENE; TUNISIAN;

AGED; AGED, 80 AND OVER; ALLELES; ARABS; CASE-CONTROL STUDIES; CHROMOSOME MAPPING; COHORT STUDIES; GENETIC PREDISPOSITION TO DISEASE; GENOME; GENOME-WIDE ASSOCIATION STUDY; GENOTYPE; HUMANS; MALE; OLIGONUCLEOTIDE ARRAY SEQUENCE ANALYSIS; POLYMORPHISM, SINGLE NUCLEOTIDE; PROSTATE-SPECIFIC ANTIGEN; PROSTATIC NEOPLASMS; QATAR; QUANTITATIVE TRAIT LOCI; REPRODUCIBILITY OF RESULTS; RISK FACTORS; RNA, MESSENGER; SAUDI ARABIA; TUNISIA;

EID: 84877628041     PISSN: None     EISSN: 14795876     Source Type: Journal    
DOI: 10.1186/1479-5876-11-121     Document Type: Article

References (47)

1. Edwards BK, Brown ML, Wingo PA. Annual report to the nation on the status of cancer, 1975-2002, featuring population-based trends in cancer treatment. J Natl Cancer Inst 2005, 97:1407-1427. 10.1093/jnci/dji289, 16204691.
2. Salim EI, Moore MA, Al-Lawati JA, Al-Sayyad J, Bazawir A. Cancer epidemiology and control in the arab world - past, present and future. Asian Pac J Cancer Prev 2009, 10:3-16.
3. Bener A, Ayub H, Kakil R, Ibrahim W. Patterns of cancer incidence among the population of Qatar: a worldwide comparative study. Asian Pac J Cancer Prev 2008, 9:19-24.
4. Kehinde EO, Akanji AO, Al-Hunayan A. Do differences in age specific androgenic steroid hormone levels account for differing prostate cancer rates between Arabs and Caucasians?. Int J Urol 2006, 13:354-361. 10.1111/j.1442-2042.2006.01305.x, 16734850.
5. Khouaja K, Ben Sorba N, Bouslama A. An experience of individual and early diagnosis of prostate cancer in a Tunisian centre. Prog Urol 2005, 15:255-259.
6. Shamseddine A, Sibai AM, Gehchan N. Cancer incidence in Postwar Lebanon: Findings from the first National Population-based Registry, 1998. Ann Epidemiol 2004, 14:663-668. 10.1016/j.annepidem.2003.12.002, 15380797.
7. Morgan R, Thornton S, El-Derery A, Hastle C. Prostate Cancer - What can be relevant from global populations? 2007, 63. Dubai, United Arab Emirates, Proceedings of the 2nd Pan Arab human Genetics Conference: 20-22 November 2007, 3654090, 23682336.
8. Hindorff LA, Sethupathy P, Junkins HA, Ramos EM, Mehta JP, Collins FS, Manolio TA. Potential etiologic and functional implications of genome-wide association loci for human diseases and traits. Proc Natl Acad Sci USA 2009, 106:9362-9367. 10.1073/pnas.0903103106, 2687147, 19474294.
9. GWAS catalog http://www.genome.gov/gwastudies.
10. Rossen EM, Fan S, Goldberg ID. BRCA1 and prostate cancer. Cancer Invest 2001, 19:396-412. 10.1081/CNV-100103134, 11405179.
11. Amundadottir LT, Sulem P, Gudmundsson J. A common variant associated with prostate cancer in European and African populations. Nat Genet 2006, 38:652-658. 10.1038/ng1808, 16682969.
12. Freedman ML, Haiman CA, Patterson N. Admixture mapping identifies 8q24 as a prostate cancer risk locus in African-American men. Proc Natl Acad Sci USA 2006, 103:14068-14073. 10.1073/pnas.0605832103, 1599913, 16945910.
13. Korn JM, Kuruvilla FG, McCarroll SA, Wysoker A, Nemesh J. Integrated genotype calling and association analysis of SNPs, common copy number polymorphisms and rare CNVs. Nat Genet 2008, 40:1253-1260. 10.1038/ng.237, 2756534, 18776909.
14. Purcell S, Neale B, Todd-Brown K, Thomas L, Ferreira MA. PLINK: a tool set for whole-genome association and population-based linkage analyses. Am J Hum Genet 2007, 81:559-575. 10.1086/519795, 1950838, 17701901.
15. Barrett JC, Fry B, Maller J, Daly MJ. Haploview: analysis and visualization of LD and haplotype maps. Bioinformatics 2005, 21:263-265. 10.1093/bioinformatics/bth457, 15297300.
16. Yang TP, Beazley C, Montgomery SB, Dimas AS, Gutierrez-Arcelus M. Genevar: a database and Java application for the analysis and visualization of SNP-gene associations in eQTL studies. Bioinformatics 2010, 26:2474-2476. 10.1093/bioinformatics/btq452, 2944204, 20702402.
17. Dimas AS, Deutsch S, Stranger BE, Montgomery SB, Borel C. Common regulatory variation impacts gene expression in a cell type-dependent manner. Science 2009, 325:1246-1250. 10.1126/science.1174148, 2867218, 19644074.
18. Nica AC, Parts L, Glass D, Nisbet J, Barrett A. The architecture of gene regulatory variation across multiple human tissues: the MuTHER study. PLoS Genet 2011, 7:e1002003. 10.1371/journal.pgen.1002003, 3033383, 21304890.
19. Wolf M, Mousses S, Hautaniemi S, Karhu R, Huusko P. High resolution analysis of gene copy number alterations in human prostate cancer using CGH on cDNA microarrays: impact of copy number on gene expression. Neoplasia 2004, 6:240-247. 10.1593/neo.03439, 1502104, 15153336.
20. Kwon EM, Salinas CA, Kolb S, Fu R, Feng Z, Stanford JL, Ostrander EA. Genetic polymorphisms in inflammation pathway genes and prostate cancer risk. Cancer Epidemiol Biomarkers Prev 2011, 20:923-933. 10.1158/1055-9965.EPI-10-0994, 3140053, 21430300.
21. Ahonen TJ, Xie J, LeBaron MJ, Zhu J, Nurmi M, Alanen K, Rui H, Nevalainen MT. Inhibition of transcription factor Stat5 induces cell death of human prostate cancer cells. J Biol Chem 2003, 278:27287-27292. 10.1074/jbc.M304307200, 12719422.
22. Li H, Zhang Y, Glass A, Zellweger T, Gehan E, Bubendorf L, Gelmann EP, Nevalainen MT. Activation of signal transducer and activator of transcription-5 in prostate cancer predicts early recurrence. Clin Cancer Res 2005, 11:5863-5868. 10.1158/1078-0432.CCR-05-0562, 16115927.
23. Li H, Ahonen TJ, Alanen K, Xie J, LeBaron MJ. Activation of signal transducer and activator of transcription 5 in human prostate cancer is associated with high histological grade. Cancer Res 2004, 64:4774-4782. 10.1158/0008-5472.CAN-03-3499, 15256446.
24. Mora LB, Buettner R, Seigne J, Diaz J, Ahmad N. Constitutive activation of Stat3 in human prostate tumors and cell lines: direct inhibition of Stat3 signaling induces apoptosis of prostate cancer cells. Cancer Res 2002, 62:6659-6666.
25. Dagvadorj A, Kirken RA, Leiby B, Karras J, Nevalainen MT. Transcription factor signal transducer and activator of transcription 5 promotes growth of human prostate cancer cells in vivo. Clin Cancer Res 2008, 14:1317-1324. 10.1158/1078-0432.CCR-07-2024, 18316550.
26. Barton BE, Karras JG, Murphy TF, Barton A, Huang HF. Signal transducer and activator of transcription 3 (STAT3) activation in prostate cancer: Direct STAT3 inhibition induces apoptosis in prostate cancer lines. Mol Cancer Ther 2004, 3:11-20. 10.1186/1476-4598-3-11, 14749471.
27. Gu L, Vogiatzi P, Puhr M, Dagvadorj A, Lutz J. Stat5 promotes metastatic behavior of human prostate cancer cells in vitro and in vivo. Endocr Relat Cancer 2010, 17:481-493. 10.1677/ERC-09-0328, 20233708.
28. Abdulghani J, Gu L, Dagvadorj A, Lutz J, Leiby B. Stat3 promotes metastatic progression of prostate cancer. Am J Pathol 2008, 172:1717-1728. 10.2353/ajpath.2008.071054, 2408430, 18483213.
29. Gu L, Dagvadorj A, Lutz J, Leiby B, Bonuccelli G. Transcription factor Stat3 stimulates metastatic behavior of human prostate cancer cells in vivo, whereas Stat5b has a preferential role in the promotion of prostate cancer cell viability and tumor growth. Am J Pathol 2010, 176:1959-1972. 10.2353/ajpath.2010.090653, 2843484, 20167868.
30. Rosson GB, Bartlett C, Reed W, Weissman BE. BRG1 loss in MiaPaCa2 cells induces an altered cellular morphology and disruption in the organization of the actin cytoskeleton. J Cell Physiol 2005, 205:286-294. 10.1002/jcp.20397, 15887247.
31. Shen H, Powers N, Saini N, Comstock CE, Sharma A. The SWI/SNF ATPase Brm is a gatekeeper of proliferative control in prostate cancer. Cancer Res 2008, 68:10154-10162. 10.1158/0008-5472.CAN-08-1794, 2858924, 19074882.
32. White KL, Sellers TA, Fridley BL, Vierkant RA, Phelan CM. Variation at 8q24 and 9p24 and risk of epithelial ovarian cancer. Twin Res Hum Genet 2010, 13:43-56. 10.1375/twin.13.1.43, 2932441, 20158306.
33. Poynter JN, Figueiredo JC, Conti DV, Kennedy K, Gallinger S. Variants on 9p24 and 8q24 are associated with risk of colorectal cancer: results from the Colon Cancer Family Registry. Cancer Res 2007, 67:11128-11132. 10.1158/0008-5472.CAN-07-3239, 18056436.
34. Castells A, Gusella JF, Ramesh V, Rustgi AK. A region of deletion on chromosome 22q13 is common to human breast and colorectal cancers. Cancer Res 2000, 60:2836-2839.
35. Chang BL, Isaacs SD, Wiley KE, Gillanders EM, Zheng SL. Genome-wide screen for prostate cancer susceptibility genes in men with clinically significant disease. Prostate 2005, 64:356-361. 10.1002/pros.20249, 15754351.
36. Stanford JL, McDonnell SK, Friedrichsen DM, Carlson EE, Kolb S. Prostate cancer and genetic susceptibility: a genome scan incorporating disease aggressiveness. Prostate 2006, 66:317-325. 10.1002/pros.20349, 16245279.
37. Lei K, Zhu X, Xu R, Shao C, Xu T, Zhuang Y, Han M. Inner Nuclear Envelope Proteins SUN1 and SUN2 Play a Prominent Role in the DNA Damage Response. Curr Biol 2012, 22:1609-1615. 10.1016/j.cub.2012.06.043, 3466333, 22863315.
38. Stieler K, Fischer N. Apobec 3G Efficiently Reduces Infectivity of the Human Exogenous Gammaretrovirus XMRV. PLoS One 2010, 5:e11738. 10.1371/journal.pone.0011738, 2909211, 20668529.
39. Ding Q, Chang CJ, Xie X, Xia W, Yang JY. APOBEC3G promotes liver metastasis in an orthotopic mouse model of colorectal cancer and predicts human hepatic metastasis. J Clin Invest 2011, 121:4526-4536. 10.1172/JCI45008, 3204827, 21985787.
40. Amin Al Olama A, Kote-Jarai Z, Schumacher FR, Wiklund F, Berndt SI. A meta-analysis of genome-wide association studies to identify prostate cancer susceptibility loci associated with aggressive and non-aggressive disease. Hum Mol Genet 2013, 22:408-415. 10.1093/hmg/dds425, 23065704.
41. Gaibar M, Esteban E, Harich N, Kandil M, Fernández-Santander A. Genetic differences among North African Berber and Arab-speaking populations revealed by Y-STR diversity. Ann Hum Biol 2011, 38:228-236. 10.3109/03014460.2010.514862, 20854231.
42. Hunter-Zinck H, Musharoff S, Salit J, Al-Ali KA, Chouchane L. Population genetic structure of the people of Qatar. Am J Hum Genet 2010, 87:17-25. 10.1016/j.ajhg.2010.05.018, 2896773, 20579625.
43. Henn BM, Botigué LR, Gravel S, Wang W, Brisbin A. Genomic ancestry of North Africans supports back-to-Africa migrations. PLoS Genet 2012, 8:e1002397. 10.1371/journal.pgen.1002397, 3257290, 22253600.
44. Takata R, Akamatsu S, Kubo M, Takahashi A, Hosono N. Genome-wide association study identifies five new susceptibility loci for prostate cancer in the Japanese population. Nat Genet 2010, 42:751-754. 10.1038/ng.635, 20676098.
45. Long QZ, Du YF, Ding XY, Li X, Song WB. Replication and fine mapping for association of the C2orf43, FOXP4, GPRC6A and RFX6 genes with prostate cancer in the Chinese population. PLoS One 2012, 7:e37866. 10.1371/journal.pone.0037866, 3360662, 22662242.
46. Klein RJ, Zeiss C, Chew EY, Tsai JY, Sackler RS. Complement factor H polymorphism in age-related macular degeneration. Science 2005, 308:385-389. 10.1126/science.1109557, 1512523, 15761122.
47. Robbins CM, Hooker S, Kittles RA, Carpten JD. EphB2 SNPs and sporadic prostate cancer risk in african american men. PLoS One 2011, 6:e19494. 10.1371/journal.pone.0019494, 3095601, 21603658.